{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:38:34Z","timestamp":1790890714206,"version":"4.1.0"},"reference-count":162,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00296","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T04:12:06Z","timestamp":1541131926000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":121,"title":["Diagnosis of Autoimmune Blistering Diseases"],"prefix":"10.3389","volume":"5","author":[{"given":"Mareike","family":"Witte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet Lond Engl."},{"key":"B3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3238\/arztebl.2011.0405","article-title":"The diagnosis and treatment of autoimmune blistering skin diseases","volume":"108","author":"Schmidt","year":"2011","journal-title":"Dtsch Arzteblatt Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.autrev.2010.08.007","article-title":"Modern diagnosis of autoimmune blistering skin diseases","volume":"10","author":"Schmidt","year":"2010","journal-title":"Autoimmun Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/bjd.13189","article-title":"Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital","volume":"171","author":"F\u00f6rsti","year":"2014","journal-title":"Br J Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris\u2013incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00403-017-1778-4","article-title":"Incidence of bullous pemphigoid in Sweden 2005-2012: a nationwide population-based cohort study of 3761 patients","volume":"309","author":"Thorslund","year":"2017","journal-title":"Arch Dermatol Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1610-0387.2008.06976_supp.x","article-title":"Prospektive Untersuchung der Inzidenz blasenbildender Autoimmundermatosen in Unterfranken","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/exd.13401","article-title":"Neurological and psychiatric associations in bullous pemphigoid-more than skin deep?","volume":"26","author":"F\u00f6rsti","year":"2017","journal-title":"Exp Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/bjd.14821","article-title":"Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A","volume":"176","author":"Ren","year":"2017","journal-title":"Br J Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"A379","DOI":"10.1016\/j.autrev.2009.10.009","article-title":"Geoepidemiologic considerations of auto-immune pemphigus","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmun Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res."},{"key":"B16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/1523-1747.ep12612836","article-title":"Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women","volume":"104","author":"Bastuji-Garin","year":"1995","journal-title":"J Invest Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jaut.2008.08.003","article-title":"Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity","volume":"31","author":"Culton","year":"2008","journal-title":"J Autoimmun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany","volume":"136","author":"H\u00fcbner","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/archderm.1942.01500180020004","article-title":"Pemphigus: a historical study","volume":"46","author":"Lever","year":"1942","journal-title":"Arch Dermatol Syphilol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine"},{"key":"B21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3181\/00379727-117-29622","article-title":"Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining","volume":"117","author":"Beutner","year":"1964","journal-title":"Proc Soc Exp Biol Med."},{"key":"B22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.1967.03120220053008","article-title":"Basement zone antibodies in bullous pemphigoid","volume":"200","author":"Jordon","year":"1967","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1582-4934.2007.00033.x","article-title":"Immunopathology and molecular diagnosis of autoimmune bullous diseases","volume":"11","author":"Mihai","year":"2007","journal-title":"J Cell Mol Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest."},{"key":"B26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2133.1998.02502.x","article-title":"Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (alpha3beta3gamma2)","volume":"139","author":"Lazarova","year":"1998","journal-title":"Br J Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ajpath.2014.05.007","article-title":"Fc\u03b3 receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid","volume":"184","author":"Schulze","year":"2014","journal-title":"Am J Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.jid.2017.03.037","article-title":"Experimental laminin 332 mucous membrane pemphigoid critically involves C5aR1 and reflects clinical and immunopathological characteristics of the human disease","volume":"137","author":"Heppe","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMra061111","article-title":"Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome","volume":"355","author":"Stanley","year":"2006","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1517\/14728222.2016.1148686","article-title":"Discovering potential drug-targets for personalized treatment of autoimmune disorders-what we learn from epidermolysis bullosa acquisita","volume":"20","author":"Witte","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"B32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fimmu.2018.00136","article-title":"Pemphigus-A disease of desmosome dysfunction caused by multiple mechanisms","volume":"9","author":"Spindler","year":"2018","journal-title":"Front Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jid.2017.06.022","article-title":"Mechanisms causing loss of keratinocyte cohesion in pemphigus","volume":"138","author":"Spindler","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000368347","article-title":"Michel's transport medium as an alternative to liquid nitrogen for PCR analysis of skin biopsy specimens","volume":"1","author":"Boraiy","year":"2014","journal-title":"Dermatopathology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/ddg.12612","article-title":"S2k guideline for the diagnosis of pemphigus vulgaris\/foliaceus and bullous pemphigoid","volume":"13","author":"Schmidt","year":"2015","journal-title":"J Dtsch Dermatol Ges."},{"key":"B37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2133.2004.06006.x","article-title":"U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases","volume":"151","author":"Vodegel","year":"2004","journal-title":"Br J Dermatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2133.2011.10474.x","article-title":"Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients","volume":"165","author":"Terra","year":"2011","journal-title":"Br J Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jaad.2017.11.029","article-title":"Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases","volume":"78","author":"Meijer","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/cup.12637","article-title":"Automated direct immunofluorescence analyses of skin biopsies","volume":"43","author":"Lemcke","year":"2016","journal-title":"J Cutan Pathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","article-title":"Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid","volume":"69","author":"S\u00e1rdy","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1440-0960.2005.00191.x","article-title":"Comparison of desmoglein ELISA and indirect immunofluorescence using two substrates (monkey oesophagus and normal human skin) in the diagnosis of pemphigus","volume":"46","author":"Ng","year":"2005","journal-title":"Australas J Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1046\/j.1365-2133.2000.03538.x","article-title":"The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus","volume":"142","author":"Harman","year":"2000","journal-title":"Br J Dermatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1046\/j.1365-2133.2003.05316.x","article-title":"Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting","volume":"148","author":"Oyama","year":"2003","journal-title":"Br J Dermatol."},{"key":"B45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2133.1992.tb00651.x","article-title":"Serological diagnosis of bullous pemphigoid (BP): comparison of the sensitivity of indirect immunofluorescence on salt-split skin to immunoblotting","volume":"126","author":"Machado","year":"1992","journal-title":"Br J Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0625.2010.01069.x","article-title":"Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients","volume":"19","author":"Schmidt","year":"2010","journal-title":"Exp Dermatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","article-title":"Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.jaad.2011.12.032","article-title":"Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita","volume":"68","author":"Komorowski","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jdermsci.2011.03.003","article-title":"Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients","volume":"62","author":"Saleh","year":"2011","journal-title":"J Dermatol Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Bl\u00f6cker","year":"2012","journal-title":"Br J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.autrev.2012.07.006","article-title":"Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis","volume":"12","author":"Tampoia","year":"2012","journal-title":"Autoimmun Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archderm.141.6.705","article-title":"Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy","volume":"141","author":"Powell","year":"2005","journal-title":"Arch Dermatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jaad.2016.09.030","article-title":"Sensitivity and specificity of BP180 NC16A enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis","volume":"76","author":"Al Saif","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/archdermatol.2011.23","article-title":"Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients","volume":"147","author":"Charneux","year":"2011","journal-title":"Arch Dermatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/archdermatol.2011.21","article-title":"Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid","volume":"147","author":"Roussel","year":"2011","journal-title":"Arch Dermatol."},{"key":"B58","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clin Chim Acta"},{"key":"B61","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jaad.2011.02.025","volume":"66","author":"Kasperkiewicz","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1365-2230.2009.03241.x","article-title":"Autoantibodies against desmocollins in European patients with pemphigus","volume":"34","author":"M\u00fcller","year":"2009","journal-title":"Clin Exp Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/bjd.13711","article-title":"Anti-desmocollin autoantibodies in nonclassical pemphigus","volume":"173","author":"Ishii","year":"2015","journal-title":"Br J Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2133.2010.10056.x","article-title":"Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid","volume":"164","author":"Groth","year":"2011","journal-title":"Br J Dermatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1073\/pnas.0809230106","article-title":"Anti-laminin gamma-1 pemphigoid","volume":"106","author":"Dainichi","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-6-31","article-title":"Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases","volume":"6","author":"Csorba","year":"2011","journal-title":"Orphanet J Rare Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody Profile Differentiates between Inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.0022-202X.2005.23646.x","article-title":"Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA","volume":"124","author":"Bekou","year":"2005","journal-title":"J Invest Dermatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamadermatol.2013.1434","article-title":"Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid","volume":"149","author":"Bernard","year":"2013","journal-title":"JAMA Dermatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2017","journal-title":"Br J Dermatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity","volume":"153","author":"van Beek","year":"2017","journal-title":"JAMA Dermatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","article-title":"A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid","volume":"346","author":"Messingham","year":"2009","journal-title":"J Immunol Methods"},{"key":"B73","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jaad.2016.11.002","article-title":"Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases","volume":"76","author":"van Beek","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1684\/ejd.2015.2692","article-title":"Diagnostic performance of the \u201cMESACUP anti-Skin profile TEST","volume":"26","author":"Horv\u00e1th","year":"2016","journal-title":"Eur J Dermatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-7-49","article-title":"Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy","volume":"7","author":"van Beek","year":"2012","journal-title":"Orphanet J Rare Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000339776","article-title":"Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases","volume":"225","author":"Tampoia","year":"2012","journal-title":"Dermatology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.acthis.2013.12.012","article-title":"The use of biochip immunofluorescence microscopy for the diagnosis of Pemphigus vulgaris","volume":"116","author":"Russo","year":"2014","journal-title":"Acta Histochem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijwd.2017.10.001","article-title":"New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: a review of the literature","volume":"4","author":"Xuan","year":"2018","journal-title":"Int J Womens Dermatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00403-016-1632-0","article-title":"The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita","volume":"308","author":"Marzano","year":"2016","journal-title":"Arch Dermatol Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/exd.13409","article-title":"Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus","volume":"26","author":"Mindorf","year":"2017","journal-title":"Exp Dermatol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17202","article-title":"Sensitive and specific assay for the serological diagnosis of anti-laminin 332 mucous membrane pemphigoid","author":"Goletz","year":"2018","journal-title":"Br J Dermatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1610-0387.2010.07380.x","article-title":"Clinical and immunopathological spectrum of paraneoplastic pemphigus","volume":"8","author":"Zimmermann","year":"2010","journal-title":"J Dtsch Dermatol Ges."},{"key":"B85","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1365-2133.2009.09566.x","article-title":"Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses","volume":"162","author":"Grootenboer-Mignot","year":"2010","journal-title":"Br J Dermatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.4049\/jimmunol.176.3.1968","article-title":"Identification of an epitope within human integrin alpha 6 subunit for the binding of autoantibody and its role in basement membrane separation in oral pemphigoid","volume":"176","author":"Rashid","year":"2006","journal-title":"J Immunol."},{"key":"B87","first-page":"83","article-title":"The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease","volume":"8","author":"Vodegel","year":"1998","journal-title":"Eur J Dermatol EJD."},{"key":"B88","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1610-0387.2011.07840.x","article-title":"Diagnostics of autoimmune bullous diseases in German dermatology departments","volume":"10","author":"van Beek","year":"2012","journal-title":"J Dtsch Dermatol Ges."},{"key":"B89","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaad.2005.10.019","article-title":"The specificity and sensitivity of nikolskiy sign in the diagnosis of pemphigus","volume":"54","author":"Uzun","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.det.2011.03.012","article-title":"Diagnosis and clinical features of pemphigus foliaceus","volume":"29","author":"James","year":"2011","journal-title":"Dermatol Clin."},{"key":"B91","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.4049\/jimmunol.136.4.1227","article-title":"A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus","volume":"136","author":"Stanley","year":"1986","journal-title":"J Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000246923","article-title":"Pemphigus vulgaris antigen is a desmosomal desmoglein","volume":"189","author":"K\u00e1rp\u00e1ti","year":"1994","journal-title":"Dermatolology"},{"key":"B93","first-page":"77","article-title":"Paraneoplastic pemphigus","volume":"12","author":"Anhalt","year":"1997","journal-title":"Adv Dermatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic pemphigus","volume":"9","author":"Anhalt","year":"2004","journal-title":"J Invest Dermatol Symp Proc."},{"key":"B95","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/CCID.S100802","article-title":"Paraneoplastic pemphigus: a short review","volume":"9","author":"Czernik","year":"2016","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000489602","article-title":"Paraneoplastic pemphigus as a first manifestation of an intra-abdominal follicular dendritic cell sarcoma: rare case and review of the literature","author":"Akel","year":"2018","journal-title":"Case Rep Oncol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5114\/ada.2018.73171","article-title":"Paraneoplastic pemphigus with anti-desmocollin 3 autoantibodies and chronic lymphocytic leukemia","volume":"35","author":"Adaszewska","year":"2018","journal-title":"Adv Dermatol Allergol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/j.1365-2133.2003.05659.x","article-title":"Paraneoplastic pemphigus in association with Castleman's disease","volume":"149","author":"Nikolskaia","year":"2003","journal-title":"Br J Dermatol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/JID.2015.408","article-title":"Epiplakin is a paraneoplastic pemphigus autoantigen and related to bronchiolitis obliterans in Japanese patients","volume":"136","author":"Tsuchisaka","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e12250","DOI":"10.1371\/journal.pone.0012250","article-title":"The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human","volume":"5","author":"Schepens","year":"2010","journal-title":"PLoS ONE"},{"key":"B101","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/sj.jid.5700198","article-title":"Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients","volume":"126","author":"Zhang","year":"2006","journal-title":"J Invest Dermatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1046\/j.1523-1747.2001.01263.x","article-title":"Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin","volume":"116","author":"Nagata","year":"2001","journal-title":"J Invest Dermatol."},{"key":"B103","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0092-8674(81)90115-X","article-title":"Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia","volume":"24","author":"Stanley","year":"1981","journal-title":"Cell"},{"key":"B104","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13023-014-0185-6","article-title":"Bullous pemphigoid in infants: characteristics, diagnosis and treatment","volume":"9","author":"Schwieger-Briel","year":"2014","journal-title":"Orphanet J Rare Dis."},{"key":"B105","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s001050051001","article-title":"Immunopathologic changes in 115 patients with bullous pemphigoid","volume":"50","author":"Kippes","year":"1999","journal-title":"Hautarzt Z Dermatol Venerol Verwandte Geb."},{"key":"B106","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.det.2011.03.010","article-title":"Clinical features and practical diagnosis of bullous pemphigoid","volume":"29","author":"Schmidt","year":"2011","journal-title":"Dermatol Clin."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1365-2133.2012.11108.x","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort","volume":"167","author":"della Torre","year":"2012","journal-title":"Br J Dermatol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fimmu.2018.00479","article-title":"Mucosal involvement in bullous pemphigoid is mostly associated with disease severity and to absence of anti-BP230 autoantibody","volume":"9","author":"Clap\u00e9","year":"2018","journal-title":"Front Immunol."},{"key":"B109","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1523-1747.ep12616580","article-title":"Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180","volume":"99","author":"Giudice","year":"1992","journal-title":"J Invest Dermatol."},{"key":"B110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/1523-1747.ep12319337","article-title":"The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane","volume":"109","author":"Masunaga","year":"1997","journal-title":"J Invest Dermatol."},{"key":"B111","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.0022-202X.2003.22126.x","article-title":"Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients","volume":"122","author":"Di Zenzo","year":"2004","journal-title":"J Invest Dermatol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1600-0625.2010.01080.x","article-title":"IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis","volume":"19","author":"Horv\u00e1th","year":"2010","journal-title":"Exp Dermatol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/jaut.2000.0437","article-title":"Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180","volume":"15","author":"Kromminga","year":"2000","journal-title":"J Autoimmun."},{"key":"B116","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/1744666X.2016.1123092","article-title":"IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases","volume":"12","author":"van Beek","year":"2016","journal-title":"Expert Rev Clin Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1046\/j.1523-1747.2000.00893.x","article-title":"IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230","volume":"114","author":"Skaria","year":"2000","journal-title":"J Invest Dermatol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1034\/j.1600-0625.2001.100405.x","article-title":"Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule","volume":"10","author":"Hamada","year":"2001","journal-title":"Exp Dermatol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1684\/ejd.2015.2719","article-title":"Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins","volume":"26","author":"Hayakawa","year":"","journal-title":"Eur J Dermatol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00403-018-1817-9","article-title":"BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid","volume":"310","author":"Daneshpazhooh","year":"2018","journal-title":"Arch Dermatol Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.det.2011.03.002","article-title":"Pemphigoid gestationis: pathogenesis and clinical features","volume":"29","author":"Intong","year":"2011","journal-title":"Dermatol Clin."},{"key":"B122","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13023-014-0136-2","article-title":"Gestational pemphigoid","volume":"9","author":"Huilaja","year":"2014","journal-title":"Orphanet J Rare Dis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2340\/00015555-2460","article-title":"Value of BIOCHIP technology in the serological diagnosis of pemphigoid gestationis","volume":"97","author":"Sadik","year":"2017","journal-title":"Acta Derm Venereol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1046\/j.1523-1747.1999.00622.x","article-title":"IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis","volume":"113","author":"Chimanovitch","year":"1999","journal-title":"J Invest Dermatol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00105-017-4089-y","article-title":"Mucous membrane pemphigoid","volume":"69","author":"Holtsche","year":"2018","journal-title":"Hautarzt Z Dermatol Venerol Verwandte Geb."},{"key":"B127","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1111\/jdv.14873","article-title":"Intravenous immunoglobulins for rituximab-resistant mucous membrane pemphigoid","volume":"32","author":"Witte","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-2133.2005.06998.x","article-title":"Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity","volume":"154","author":"Oyama","year":"2006","journal-title":"Br J Dermatol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1172\/JCI116033","article-title":"Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease","volume":"90","author":"Domloge-Hultsch","year":"1992","journal-title":"J Clin Invest."},{"key":"B131","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/1523-1747.ep12323431","article-title":"Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5","volume":"105","author":"Kirtschig","year":"1995","journal-title":"J Invest Dermatol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","article-title":"Anti-epiligrin cicatricial pemphigoid and relative risk for cancer","volume":"357","author":"Egan","year":"2001","journal-title":"Lancet Lond Engl."},{"key":"B133","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.135.9.1091","article-title":"Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?","volume":"135","author":"Leverkus","year":"1999","journal-title":"Arch Dermatol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1038\/sj.jid.5700465","article-title":"Antigen specificity in subsets of mucous membrane pemphigoid","volume":"126","author":"Rashid","year":"2006","journal-title":"J Invest Dermatol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000279318","article-title":"Linear IgA disease: successful application of immunoadsorption and review of the literature","volume":"220","author":"Kasperkiewicz","year":"2010","journal-title":"Dermatology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.det.2011.03.022","article-title":"Clinical features, diagnosis, and pathogenesis of chronic bullous disease of childhood","volume":"29","author":"Mintz","year":"2011","journal-title":"Dermatol Clin."},{"key":"B137","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2133.1991.tb00425.x","article-title":"Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults","volume":"124","author":"Wojnarowska","year":"1991","journal-title":"Br J Dermatol."},{"key":"B138","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/1523-1747.ep12345782","article-title":"LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells","volume":"106","author":"Marinkovich","year":"1996","journal-title":"J Invest Dermatol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1523-1747.1998.00129.x","article-title":"The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2","volume":"110","author":"Zone","year":"1998","journal-title":"J Invest Dermatol."},{"key":"B140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-0560.1990.tb00073.x","article-title":"Use of 1M NaCl split skin in the indirect immunofluorescence of the linear IgA bullous dermatoses","volume":"17","author":"Willsteed","year":"1990","journal-title":"J Cutan Pathol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1046\/j.1523-1747.1999.00808.x","article-title":"Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801","volume":"113","author":"Zillikens","year":"1999","journal-title":"J Invest Dermatol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/jid.2014.381","article-title":"Type VII collagen is the major autoantigen for sublamina densa-type linear IgA bullous dermatosis","volume":"135","author":"Tsuchisaka","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.jid.2017.12.035","article-title":"Vancomycin mediates IgA autoreactivity in drug-induced linear iga bullous dermatosis","volume":"138","author":"Yamagami","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/bjd.16138","article-title":"International bullous diseases group: consensus on diagnostic criteria for epidermolysis bullosa acquisita","volume":"179","author":"Prost-Squarcioni","year":"2017","journal-title":"Br J Dermatol."},{"key":"B145","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/1523-1747.ep12349283","article-title":"A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone","volume":"106","author":"Zillikens","year":"1996","journal-title":"J Invest Dermatol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jaad.2014.02.036","article-title":"Anti-p200 pemphigoid","volume":"71","author":"Goletz","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1346-8138.2009.00793.x","article-title":"From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid","volume":"37","author":"Dainichi","year":"2010","journal-title":"J Dermatol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJM198404193101602","article-title":"Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita","volume":"310","author":"Woodley","year":"1984","journal-title":"N Engl J Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/1744666X.2016.1221343","article-title":"Clinical features and diagnosis of epidermolysis bullosa acquisita","volume":"13","author":"Vorobyev","year":"2017","journal-title":"Expert Rev Clin Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"812029","DOI":"10.1155\/2013\/812029","article-title":"Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita","volume":"2013","author":"Ludwig","year":"2013","journal-title":"ISRN Dermatol."},{"key":"B151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archderm.1971.04000130003001","article-title":"Epidermolysis bullosa acquisita","volume":"103","author":"Roenigk","year":"1971","journal-title":"Arch Dermatol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1365-2133.2011.10346.x","article-title":"The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy","volume":"165","author":"Buijsrogge","year":"2011","journal-title":"Br J Dermatol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1172\/JCI116774","article-title":"Epitope mapping of type VII collagen","volume":"92","author":"Lapiere","year":"1993","journal-title":"J Clin Invest."},{"key":"B154","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1365-2133.2004.05933.x","article-title":"Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy","volume":"150","author":"Ishii","year":"2004","journal-title":"Br J Dermatol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1111\/j.1468-3083.2012.04617.x","article-title":"Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions","volume":"27","author":"Kim","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2133.2006.07739.x","article-title":"Blindness due to the IgA variant of epidermolysis bullosa acquisita, and treatment with osteo-odonto-keratoprosthesis","volume":"156","author":"Cox","year":"2007","journal-title":"Br J Dermatol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1067\/mjd.2002.125079","article-title":"IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature","volume":"47","author":"Vodegel","year":"2002","journal-title":"J Am Acad Dermatol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"967974","DOI":"10.1155\/2012\/967974","article-title":"Newly described clinical and immunopathological feature of dermatitis herpetiformis","volume":"2012","author":"Bonciolini","year":"2012","journal-title":"Clin Dev Immunol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.jaad.2010.09.777","article-title":"Dermatitis herpetiformis. Part I. epidemiology, pathogenesis, and clinical presentation","volume":"64","author":"Bolotin","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jaad.2010.09.776","article-title":"Dermatitis herpetiformis. Part II. diagnosis, management, and prognosis","volume":"64","author":"Bolotin","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"S\u00e1rdy","year":"2002","journal-title":"J Exp Med."},{"key":"B162","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaad.2008.12.037","article-title":"Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet","volume":"61","author":"Rose","year":"2009","journal-title":"J Am Acad Dermatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T17:51:31Z","timestamp":1694022691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":162,"alternative-id":["10.3389\/fmed.2018.00296"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00296","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]},"article-number":"296"}}